Pancytopenia is defined as anemia (usually non-regenerative), neutropenia, and thrombocytopenia. It is usually due to a primary bone marrow problem, with very few extramedullary diseases that produce this constellation of hematologic abnormalities. Exceptions are severe bacterial sepsis which can result in anemia of inflammatory disease, severe neutropenia with a left shift and toxic change from inflammation, and thrombocytopenia due to concurrent endotoxemia (sequestration) or disseminated intravascular coagulation (consumption). Cytauxzoon felis and Feline Infectious Peritonitis Virus infection can also result in similar hemogram changes, likely due to similar reasons.
The following are mechanisms of pancytopenia. They can only be distinguished by aspiration of the bone marrow.
- Bone marrow aplasia: This is characterized by a lack of hematopoietic cells in the bone marrow, leaving only fat and stromal cells (lymphocytes, plasma cells, mast cells, histiocytes, fibroblasts) and occurs due to destruction or suppression of early multipotential hematopoietic stem cells. This can be due to bracken fern poisoning (cattle), drugs (chloramphenicol, griseofulvin, trimethroprim sulfonamides, chemotherapeutic agents, albendazole, fenbendazole), hormones (estrogen), immune-mediated disease, infectious agents (Ehrlichia canis). A syndrome of bovine neonatal pancytopenia has been identified in calves that present with clinical signs of hemorrhage. This is attributed to immune-mediated destruction of precursors in marrow as a consequence of bovine virus diarrhea vaccination of dams, with calves receiving offending allo-antibodies from colostrum. Although the incidence of clinical disease is low, subclinically affected calves with abnormal hemograms can be detected in herds with obvious clinical cases (Bell et al 2014). Selective absence of one cell line with normal production of cells of the other two is called pure red cell aplasia, pure white cell aplasia, or amegakaryocytosis. Immune-mediated attack on committed progenitor cells of the affected series is the apparent cause in most cases.
- Bone marrow hypoplasia: This is characterized by decreased but not absent hematopoietic cells. It can be due to the same causes as bone marrow aplasia.
- Bone marrow necrosis: Uncommon; rarely a cause of pancytopenia. This can be due to ischemic injury (vasculitis), myelotoxins (drugs), viruses (e.g. Canine parvovirus), radiation, and drugs. Core biopsy is generally considered more reliable for diagnosis than an aspirate.
- Ineffective hematopoiesis: This is associated with hyperplasia of cell lines in bone marrow but peripheral cytopenias. This can be due to bone marrow neoplasia or non-neoplastic conditions.
- Neoplasia: Myelodysplastic syndrome will result in cytopenias. There will be evidence of dysplasia (abnormal production) in some or all lines. Histiocytic sarcoma is another cause of ineffective hematopoiesis, likely due to hemophagocytosis by the tumor cells.
- Non-neoplastic conditions: Immune-mediated destruction of marrow progenitors (like non-regenerative immune-mediated anemia), drug-induced (e.g. cephalosporin, phenobarbital, azathioprine, vincristine), infectious agents (Ehrlichia canis).
- Bone marrow neoplasia: This can be due to neoplasms arising in the bone marrow (e.g. acute myeloid leukemia) or infiltrating neoplasms, which crowd out marrow cells (myelophthisis), deprive normal marrow cells of vital nutrients, or cause immune-mediated or cytokine-mediated destruction or suppression of hematopoiesis (e.g. multiple myeloma, histiocytic sarcoma, lymphoma). Both lymphoma and histiocytic sarcoma may not be diagnostic with marrow aspirates but may be reflected clinically by a lack of response to immunosuppressive therapy. Acute leukemia that arises in the marrow can also result in pancytopenia (a common presenting finding with these neoplasms).
Myelofibrosis may be seen with many of these causes and is a secondary phenomenon that may contribute but not be the primary cause of the cytopenias.